5-Amino-1MQ inhibits nicotinamide N-methyltransferase (NNMT), restoring NAD+ pools depleted in metabolic dysfunction and improving mitochondrial oxidative capacity by 6080% in preclinical models
The standard initial loading dose is 1,000 mcg administered intramuscularly (IM) once weekly for 4 weeks
The BPC-157 vote was 8 to 6
Product quality is another concern
Keep track of any symptoms or changes in your health, and report any side effects or unusual reactions to your doctor promptly
You should contact your GP, call NHS 111, or seek urgent medical advice if you are currently using unlicensed peptides and experience any of the following: Severe or persistent nausea, vomiting, or abdominal pain Signs of infection at an injection site (redness, swelling, warmth, discharge) Unexplained changes in heart rate or palpitations Symptoms of an allergic reaction (rash, swelling, difficulty breathing) Persistent right upper quadrant pain, fever, or jaundice (which may indicate gallbladder problems) Significant unintentional weight loss or fatigue Call 999 or go to your nearest emergency department if symptoms are severe or rapidly worsening